25 XP   0   0   10

Biotoxtech Co. Ltd
Buy, Hold or Sell?

Let's analyse Biotoxtech together

PenkeI guess you are interested in Biotoxtech Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotoxtech Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotoxtech Co. Ltd

I send you an email if I find something interesting about Biotoxtech Co. Ltd.

Quick analysis of Biotoxtech (30 sec.)










What can you expect buying and holding a share of Biotoxtech? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩3,028.40
Expected worth in 1 year
₩3,034.54
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
₩6.14
Return On Investment
0.1%

For what price can you sell your share?

Current Price per Share
₩5,490.00
Expected price per share
₩0 - ₩7,120
How sure are you?
50%

1. Valuation of Biotoxtech (5 min.)




Live pricePrice per Share (EOD)

₩5,490.00

Intrinsic Value Per Share

₩-16,858.55 - ₩-19,585.52

Total Value Per Share

₩-13,830.16 - ₩-16,557.12

2. Growth of Biotoxtech (5 min.)




Is Biotoxtech growing?

Current yearPrevious yearGrowGrow %
How rich?$33.7m$30.1m$4m11.9%

How much money is Biotoxtech making?

Current yearPrevious yearGrowGrow %
Making money-$853.5k$523.8k-$1.3m-161.4%
Net Profit Margin-15.1%7.3%--

How much money comes from the company's main activities?

3. Financial Health of Biotoxtech (5 min.)




What can you expect buying and holding a share of Biotoxtech? (5 min.)

Welcome investor! Biotoxtech's management wants to use your money to grow the business. In return you get a share of Biotoxtech.

What can you expect buying and holding a share of Biotoxtech?

First you should know what it really means to hold a share of Biotoxtech. And how you can make/lose money.

Speculation

The Price per Share of Biotoxtech is ₩5,490. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotoxtech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotoxtech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩3,028.40. Based on the TTM, the Book Value Change Per Share is ₩1.54 per quarter. Based on the YOY, the Book Value Change Per Share is ₩52.80 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotoxtech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.0%-0.050.0%0.060.0%0.020.0%0.020.0%
Usd Book Value Change Per Share-0.060.0%0.000.0%0.040.0%0.020.0%0.020.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.060.0%0.000.0%0.040.0%0.020.0%0.020.0%
Usd Price Per Share4.31-5.12-5.41-6.03-5.57-
Price to Earnings Ratio-260.81--83.34-21.35--11.43--2.90-
Price-to-Total Gains Ratio-70.44--64.53-158.43-23.49-28.73-
Price to Book Ratio2.03-2.35-2.64-3.45-3.58-
Price-to-Total Gains Ratio-70.44--64.53-158.43-23.49-28.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.843
Number of shares260
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.02
Usd Total Gains Per Share0.000.02
Gains per Quarter (260 shares)0.285.21
Gains per Year (260 shares)1.1220.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101-902111
202-804232
303-706353
404-608374
506-5010495
607-40125116
708-30146137
809-20167158
9010-10188179
1001100208200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%7.05.00.058.3%10.010.00.050.0%18.013.09.045.0%19.013.012.043.2%
Book Value Change Per Share1.03.00.025.0%8.04.00.066.7%12.08.00.060.0%24.016.00.060.0%25.019.00.056.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.044.00.0%
Total Gains per Share1.03.00.025.0%8.04.00.066.7%12.08.00.060.0%24.016.00.060.0%25.019.00.056.8%

Fundamentals of Biotoxtech

About Biotoxtech Co. Ltd

Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. It is involved in the PK/TK, ADME, and RI analysis, as well as validation and bio analysis; efficacy evaluation and screening materials; clinical pathology and business contract of histopathology; new drug development; and business consulting and vicegerent of nonclinical trial activities. The company's safety evaluation research field includes general toxicity studies, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity studies, immunotoxicity studies, safety pharmacology, ecotoxicology studies, histopathology/clinical pathology, and juvenile animal toxicity studies. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.

Fundamental data was last updated by Penke on 2024-04-15 13:37:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Biotoxtech Co. Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotoxtech earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Biotoxtech to the Biotechnology & Medical Research industry mean.
  • A Net Profit Margin of -1.1% means that ₩-0.01 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotoxtech Co. Ltd:

  • The MRQ is -1.1%. The company is making a loss. -1
  • The TTM is -15.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-15.1%+14.0%
TTM-15.1%YOY7.3%-22.4%
TTM-15.1%5Y1.1%-16.2%
5Y1.1%10Y3.1%-2.0%
1.1.2. Return on Assets

Shows how efficient Biotoxtech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotoxtech to the Biotechnology & Medical Research industry mean.
  • -0.1% Return on Assets means that Biotoxtech generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotoxtech Co. Ltd:

  • The MRQ is -0.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM-0.9%+0.9%
TTM-0.9%YOY0.7%-1.6%
TTM-0.9%5Y0.1%-1.1%
5Y0.1%10Y0.4%-0.2%
1.1.3. Return on Equity

Shows how efficient Biotoxtech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotoxtech to the Biotechnology & Medical Research industry mean.
  • -0.2% Return on Equity means Biotoxtech generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotoxtech Co. Ltd:

  • The MRQ is -0.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM-2.4%+2.2%
TTM-2.4%YOY1.7%-4.1%
TTM-2.4%5Y0.3%-2.7%
5Y0.3%10Y0.7%-0.4%

1.2. Operating Efficiency of Biotoxtech Co. Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotoxtech is operating .

  • Measures how much profit Biotoxtech makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotoxtech to the Biotechnology & Medical Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotoxtech Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4.2%-4.2%
TTM-5Y2.7%-2.7%
5Y2.7%10Y2.4%+0.2%
1.2.2. Operating Ratio

Measures how efficient Biotoxtech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • An Operation Ratio of 2.25 means that the operating costs are ₩2.25 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Biotoxtech Co. Ltd:

  • The MRQ is 2.251. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.048. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.251TTM2.048+0.203
TTM2.048YOY0.931+1.116
TTM2.0485Y1.194+0.854
5Y1.19410Y1.095+0.099

1.3. Liquidity of Biotoxtech Co. Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotoxtech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A Current Ratio of 0.86 means the company has ₩0.86 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotoxtech Co. Ltd:

  • The MRQ is 0.861. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.838. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.861TTM0.838+0.024
TTM0.838YOY0.899-0.061
TTM0.8385Y0.926-0.088
5Y0.92610Y0.579+0.347
1.3.2. Quick Ratio

Measures if Biotoxtech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotoxtech to the Biotechnology & Medical Research industry mean.
  • A Quick Ratio of 0.25 means the company can pay off ₩0.25 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotoxtech Co. Ltd:

  • The MRQ is 0.252. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.338. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.252TTM0.338-0.086
TTM0.338YOY1.160-0.822
TTM0.3385Y0.961-0.623
5Y0.96110Y0.593+0.368

1.4. Solvency of Biotoxtech Co. Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotoxtech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotoxtech to Biotechnology & Medical Research industry mean.
  • A Debt to Asset Ratio of 0.67 means that Biotoxtech assets are financed with 67.2% credit (debt) and the remaining percentage (100% - 67.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotoxtech Co. Ltd:

  • The MRQ is 0.672. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.629. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.672TTM0.629+0.043
TTM0.629YOY0.609+0.020
TTM0.6295Y0.542+0.087
5Y0.54210Y0.499+0.043
1.4.2. Debt to Equity Ratio

Measures if Biotoxtech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotoxtech to the Biotechnology & Medical Research industry mean.
  • A Debt to Equity ratio of 191.1% means that company has ₩1.91 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotoxtech Co. Ltd:

  • The MRQ is 1.911. The company is just able to pay all its debts with equity.
  • The TTM is 1.668. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.911TTM1.668+0.243
TTM1.668YOY1.571+0.096
TTM1.6685Y1.237+0.430
5Y1.23710Y1.066+0.171

2. Market Valuation of Biotoxtech Co. Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Biotoxtech generates.

  • Above 15 is considered overpriced but always compare Biotoxtech to the Biotechnology & Medical Research industry mean.
  • A PE ratio of -260.81 means the investor is paying ₩-260.81 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotoxtech Co. Ltd:

  • The EOD is -232.446. Based on the earnings, the company is expensive. -2
  • The MRQ is -260.813. Based on the earnings, the company is expensive. -2
  • The TTM is -83.344. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-232.446MRQ-260.813+28.368
MRQ-260.813TTM-83.344-177.470
TTM-83.344YOY21.351-104.695
TTM-83.3445Y-11.432-71.912
5Y-11.43210Y-2.900-8.532
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotoxtech Co. Ltd:

  • The EOD is 19.127. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.462. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 2.343. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD19.127MRQ21.462-2.334
MRQ21.462TTM2.343+19.119
TTM2.343YOY-4.397+6.740
TTM2.3435Y65.194-62.851
5Y65.19410Y45.957+19.237
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotoxtech is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A PB ratio of 2.03 means the investor is paying ₩2.03 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotoxtech Co. Ltd:

  • The EOD is 1.813. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.034. Based on the equity, the company is underpriced. +1
  • The TTM is 2.349. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.813MRQ2.034-0.221
MRQ2.034TTM2.349-0.315
TTM2.349YOY2.635-0.286
TTM2.3495Y3.446-1.096
5Y3.44610Y3.577-0.131
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biotoxtech Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---87.4441.536-5795%52.800-266%28.628-405%31.745-375%
Book Value Per Share--3028.3973126.635-3%2938.737+3%2587.694+17%2238.364+35%
Current Ratio--0.8610.838+3%0.899-4%0.926-7%0.579+49%
Debt To Asset Ratio--0.6720.629+7%0.609+10%0.542+24%0.499+35%
Debt To Equity Ratio--1.9111.668+15%1.571+22%1.237+54%1.066+79%
Dividend Per Share----0%-0%-0%-0%
Eps---5.905-77.600+1214%88.200-107%21.959-127%21.791-127%
Free Cash Flow Per Share--71.755-341.137+575%-781.235+1189%-235.906+429%-129.555+281%
Free Cash Flow To Equity Per Share--71.755-146.269+304%-238.146+432%-15.123+121%24.579+192%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.775+29%
Intrinsic Value_10Y_max---19585.518--------
Intrinsic Value_10Y_min---16858.554--------
Intrinsic Value_1Y_max---1701.363--------
Intrinsic Value_1Y_min---1670.998--------
Intrinsic Value_3Y_max---5311.007--------
Intrinsic Value_3Y_min---5066.307--------
Intrinsic Value_5Y_max---9160.723--------
Intrinsic Value_5Y_min---8485.609--------
Market Cap79917381000.000-23%98113473920.000113440076650.000-14%113066112750.000-13%127080988745.000-23%116629509691.483-16%
Net Profit Margin---0.011-0.151+1269%0.073-115%0.011-199%0.031-136%
Operating Margin----0%0.042-100%0.027-100%0.024-100%
Operating Ratio--2.2512.048+10%0.931+142%1.194+89%1.095+106%
Pb Ratio1.813-12%2.0342.349-13%2.635-23%3.446-41%3.577-43%
Pe Ratio-232.446+11%-260.813-83.344-68%21.351-1322%-11.432-96%-2.900-99%
Price Per Share5490.000-12%6160.0007307.500-16%7725.000-20%8618.000-29%7956.000-23%
Price To Free Cash Flow Ratio19.127-12%21.4622.343+816%-4.397+120%65.194-67%45.957-53%
Price To Total Gains Ratio-62.783+11%-70.445-64.527-8%158.428-144%23.486-400%28.732-345%
Quick Ratio--0.2520.338-26%1.160-78%0.961-74%0.593-58%
Return On Assets---0.001-0.009+1385%0.007-109%0.001-146%0.004-118%
Return On Equity---0.002-0.024+1203%0.017-111%0.003-161%0.007-126%
Total Gains Per Share---87.4441.536-5795%52.800-266%28.628-405%31.745-375%
Usd Book Value--33764381.35034188307.913-1%30108748.070+12%26885181.622+26%23067061.732+46%
Usd Book Value Change Per Share---0.0610.001-5795%0.037-266%0.020-405%0.022-375%
Usd Book Value Per Share--2.1202.189-3%2.057+3%1.811+17%1.567+35%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.004-0.054+1214%0.062-107%0.015-127%0.015-127%
Usd Free Cash Flow--800019.486-3696163.816+562%-8004123.344+1100%-2457592.019+407%-1049989.762+231%
Usd Free Cash Flow Per Share--0.050-0.239+575%-0.547+1189%-0.165+429%-0.091+281%
Usd Free Cash Flow To Equity Per Share--0.050-0.102+304%-0.167+432%-0.011+121%0.017+192%
Usd Market Cap55942166.700-23%68679431.74479408053.655-14%79146278.925-13%88956692.122-23%81640656.784-16%
Usd Price Per Share3.843-12%4.3125.115-16%5.408-20%6.033-29%5.569-23%
Usd Profit---65831.990-853586.048+1197%523892.992-113%90340.316-173%155341.814-142%
Usd Revenue--5965890.5325710420.751+4%8048601.764-26%6461361.592-8%5193616.341+15%
Usd Total Gains Per Share---0.0610.001-5795%0.037-266%0.020-405%0.022-375%
 EOD+4 -4MRQTTM+16 -16YOY+11 -225Y+12 -2110Y+15 -19

3.2. Fundamental Score

Let's check the fundamental score of Biotoxtech Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-232.446
Price to Book Ratio (EOD)Between0-11.813
Net Profit Margin (MRQ)Greater than0-0.011
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.252
Current Ratio (MRQ)Greater than10.861
Debt to Asset Ratio (MRQ)Less than10.672
Debt to Equity Ratio (MRQ)Less than11.911
Return on Equity (MRQ)Greater than0.15-0.002
Return on Assets (MRQ)Greater than0.05-0.001
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Biotoxtech Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.842
Ma 20Greater thanMa 505,751.500
Ma 50Greater thanMa 1005,836.200
Ma 100Greater thanMa 2005,977.200
OpenGreater thanClose5,430.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets147,036,242
Total Liabilities98,801,411
Total Stockholder Equity51,710,250
 As reported
Total Liabilities 98,801,411
Total Stockholder Equity+ 51,710,250
Total Assets = 147,036,242

Assets

Total Assets147,036,242
Total Current Assets64,692,236
Long-term Assets82,344,005
Total Current Assets
Cash And Cash Equivalents 27,479,366
Short-term Investments 13,559,000
Net Receivables 5,355,297
Inventory 11,915,421
Total Current Assets  (as reported)64,692,236
Total Current Assets  (calculated)58,309,083
+/- 6,383,153
Long-term Assets
Property Plant Equipment 58,181,291
Intangible Assets 1,595,628
Long-term Assets Other 0
Long-term Assets  (as reported)82,344,005
Long-term Assets  (calculated)59,776,920
+/- 22,567,086

Liabilities & Shareholders' Equity

Total Current Liabilities75,118,525
Long-term Liabilities23,682,886
Total Stockholder Equity51,710,250
Total Current Liabilities
Short Long Term Debt 41,228,685
Accounts payable 541,976
Other Current Liabilities 1
Total Current Liabilities  (as reported)75,118,525
Total Current Liabilities  (calculated)41,770,661
+/- 33,347,864
Long-term Liabilities
Long term Debt 20,000,000
Capital Lease Obligations Min Short Term Debt362,617
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)23,682,886
Long-term Liabilities  (calculated)20,362,617
+/- 3,320,268
Total Stockholder Equity
Retained Earnings 6,739,851
Total Stockholder Equity (as reported)51,710,250
Total Stockholder Equity (calculated)6,739,851
+/- 44,970,399
Other
Capital Stock7,979,124
Common Stock Shares Outstanding 15,928
Net Debt 33,749,319
Net Invested Capital 112,938,934
Net Working Capital -10,426,289
Property Plant and Equipment Gross 81,861,155



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
47,858,389
46,461,839
44,766,200
46,294,125
44,969,706
43,550,215
42,962,074
47,836,166
47,755,099
45,402,910
45,932,217
45,379,011
45,065,793
45,625,346
47,113,248
48,007,296
47,334,575
47,719,988
49,435,904
59,770,502
62,756,666
63,200,347
64,756,171
63,135,803
63,250,912
57,063,292
57,022,946
60,175,524
59,339,229
60,163,511
61,964,606
63,654,914
66,374,802
68,433,404
83,980,975
90,740,895
98,188,214
103,035,457
116,335,330
125,700,377
123,928,773
127,567,887
130,604,587
147,036,242
147,036,242130,604,587127,567,887123,928,773125,700,377116,335,330103,035,45798,188,21490,740,89583,980,97568,433,40466,374,80263,654,91461,964,60660,163,51159,339,22960,175,52457,022,94657,063,29263,250,91263,135,80364,756,17163,200,34762,756,66659,770,50249,435,90447,719,98847,334,57548,007,29647,113,24845,625,34645,065,79345,379,01145,932,21745,402,91047,755,09947,836,16642,962,07443,550,21544,969,70646,294,12544,766,20046,461,83947,858,389
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,173,038
16,734,309
13,163,621
11,616,285
13,914,122
14,814,310
15,862,206
17,130,196
14,737,564
15,437,799
17,177,529
17,306,248
24,787,776
25,848,098
27,178,004
28,465,930
28,555,591
34,799,673
37,746,103
41,796,123
48,791,132
44,803,309
49,129,838
43,994,631
47,333,150
49,218,821
64,692,236
64,692,23649,218,82147,333,15043,994,63149,129,83844,803,30948,791,13241,796,12337,746,10334,799,67328,555,59128,465,93027,178,00425,848,09824,787,77617,306,24817,177,52915,437,79914,737,56417,130,19615,862,20614,814,31013,914,12211,616,28513,163,62116,734,30915,173,03800000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,800,690
10,718,778
7,062,376
4,928,728
7,571,179
7,864,532
6,218,424
7,122,226
5,145,548
5,838,466
5,368,370
6,622,768
13,391,460
14,988,514
2,745,798
7,614,278
7,249,054
10,514,372
238
2,452
2,872
1,516
1,404
2,284
2,924
13,485,364
27,479,366
27,479,36613,485,3642,9242,2841,4041,5162,8722,45223810,514,3727,249,0547,614,2782,745,79814,988,51413,391,4606,622,7685,368,3705,838,4665,145,5487,122,2266,218,4247,864,5327,571,1794,928,7287,062,37610,718,7789,800,69000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,043,220
1,043,220
1,043,220
925,000
749,000
749,000
4,749,000
4,559,000
4,559,000
4,559,000
0
0
0
4,000,000
17,865,153
14,067,467
14,001,091
15,011,622
9,000,000
14,000,000
34,454,923
12,500,000
15,511,882
7,500,000
1,000,000
10,559,000
13,559,000
13,559,00010,559,0001,000,0007,500,00015,511,88212,500,00034,454,92314,000,0009,000,00015,011,62214,001,09114,067,46717,865,1534,000,0000004,559,0004,559,0004,559,0004,749,000749,000749,000925,0001,043,2201,043,2201,043,22000000000000000000
       Net Receivables 
5,768,938
5,100,495
5,274,541
5,417,097
4,732,189
4,138,056
4,432,301
3,986,851
3,767,265
3,744,013
3,721,074
3,822,550
3,574,605
4,642,912
4,347,024
3,542,584
2,758,219
3,382,465
4,089,216
3,962,312
4,447,106
4,221,832
4,948,176
3,755,523
3,786,509
4,009,963
3,349,819
6,102,315
5,184,969
5,986,968
5,242,344
4,948,668
4,994,704
5,458,977
7,740,896
8,630,651
7,835,635
9,487,981
11,497,937
7,488,307
6,855,005
7,270,663
5,358,749
5,355,297
5,355,2975,358,7497,270,6636,855,0057,488,30711,497,9379,487,9817,835,6358,630,6517,740,8965,458,9774,994,7044,948,6685,242,3445,986,9685,184,9696,102,3153,349,8194,009,9633,786,5093,755,5234,948,1764,221,8324,447,1063,962,3124,089,2163,382,4652,758,2193,542,5844,347,0244,642,9123,574,6053,822,5503,721,0743,744,0133,767,2653,986,8514,432,3014,138,0564,732,1895,417,0975,274,5415,100,4955,768,938
       Other Current Assets 
140,172
110,104
194,458
250,913
261,714
121,486
84,085
78,700
210,033
163,430
293,520
199,313
105,798
184,029
204,516
75,165
84,157
124,852
159,749
148,405
317,831
158,573
162,781
147,107
409,162
277,311
559,000
398,496
284,165
96,378
97,578
188,741
269,861
264,468
310,785
88,110
62,189
2,522,949
2,546,726
5,561,920
12,561,920
14,352,470
-1
-1
-1-114,352,47012,561,9205,561,9202,546,7262,522,94962,18988,110310,785264,468269,861188,74197,57896,378284,165398,496559,000277,311409,162147,107162,781158,573317,831148,405159,749124,85284,15775,165204,516184,029105,798199,313293,520163,430210,03378,70084,085121,486261,714250,913194,458110,104140,172
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,570,540
79,934,142
80,234,737
81,385,766
82,344,005
82,344,00581,385,76680,234,73779,934,14276,570,540000000000000000000000000000000000000000
       Property Plant Equipment 
23,223,857
23,036,756
22,847,992
22,573,691
22,272,526
22,058,880
21,764,713
21,551,507
21,307,175
21,020,301
20,831,398
20,811,564
20,621,385
20,591,988
20,343,280
20,081,521
20,491,105
20,463,468
20,704,810
22,317,220
23,674,149
23,585,518
23,261,967
23,060,781
22,708,124
22,554,639
22,253,490
21,964,571
21,885,860
21,820,352
22,113,255
22,054,509
24,302,645
24,545,786
24,415,001
25,408,753
27,690,195
30,447,238
53,170,955
58,066,345
58,645,058
58,275,702
58,575,017
58,181,291
58,181,29158,575,01758,275,70258,645,05858,066,34553,170,95530,447,23827,690,19525,408,75324,415,00124,545,78624,302,64522,054,50922,113,25521,820,35221,885,86021,964,57122,253,49022,554,63922,708,12423,060,78123,261,96723,585,51823,674,14922,317,22020,704,81020,463,46820,491,10520,081,52120,343,28020,591,98820,621,38520,811,56420,831,39821,020,30121,307,17521,551,50721,764,71322,058,88022,272,52622,573,69122,847,99223,036,75623,223,857
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,438,645
5,438,645
5,438,645
5,438,645
4,283,842
4,283,842
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000004,283,8424,283,8425,438,6455,438,6455,438,6455,438,6450000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,335,434
8,463,139
8,464,165
14,211,240
13,434,869
14,367,886
13,327,519
12,534,516
17,211,701
16,453,822
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000016,453,82217,211,70112,534,51613,327,51914,367,88613,434,86914,211,2408,464,1658,463,1398,335,43400000000000000000
       Intangible Assets 
225,038
208,836
186,563
178,268
159,460
141,404
124,380
3,076,886
95,512
94,968
81,333
66,216
58,091
45,554
36,835
43,397
38,023
32,889
32,052
12,170,049
11,881,185
6,156,613
5,863,495
5,570,602
5,311,103
55,025
242,876
223,722
204,575
190,291
1,261,759
1,319,698
1,326,058
1,384,595
1,404,243
1,537,151
1,504,792
1,476,982
1,469,648
1,482,671
1,586,268
1,517,750
1,630,760
1,595,628
1,595,6281,630,7601,517,7501,586,2681,482,6711,469,6481,476,9821,504,7921,537,1511,404,2431,384,5951,326,0581,319,6981,261,759190,291204,575223,722242,87655,0255,311,1035,570,6025,863,4956,156,61311,881,18512,170,04932,05232,88938,02343,39736,83545,55458,09166,21681,33394,96895,5123,076,886124,380141,404159,460178,268186,563208,836225,038
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
00011000000000000000000000000000000000000000
> Total Liabilities 
19,484,074
18,485,199
18,691,291
20,694,405
20,833,574
20,046,936
20,497,937
21,152,680
22,392,146
20,195,361
20,921,133
21,794,880
21,100,042
21,106,497
22,242,820
22,444,931
21,495,540
20,735,428
22,002,697
28,529,781
27,847,797
27,861,641
27,150,989
27,386,460
27,815,367
26,578,845
28,815,263
29,983,316
29,325,755
28,116,095
29,019,929
30,129,247
32,344,702
33,072,170
46,630,796
49,597,226
56,789,833
61,336,759
71,617,321
81,465,476
80,439,574
73,557,758
80,976,986
98,801,411
98,801,41180,976,98673,557,75880,439,57481,465,47671,617,32161,336,75956,789,83349,597,22646,630,79633,072,17032,344,70230,129,24729,019,92928,116,09529,325,75529,983,31628,815,26326,578,84527,815,36727,386,46027,150,98927,861,64127,847,79728,529,78122,002,69720,735,42821,495,54022,444,93122,242,82021,106,49721,100,04221,794,88020,921,13320,195,36122,392,14621,152,68020,497,93720,046,93620,833,57420,694,40518,691,29118,485,19919,484,074
   > Total Current Liabilities 
14,766,445
14,106,200
14,005,054
16,129,728
18,542,541
17,734,649
18,018,602
18,169,509
20,234,578
18,190,395
18,734,912
19,135,965
18,212,031
18,558,950
19,311,352
19,887,225
19,737,326
18,815,908
19,793,941
22,788,043
23,315,459
23,393,945
22,173,062
23,866,814
24,258,404
22,162,776
23,155,569
22,182,112
21,471,217
20,408,929
20,648,723
25,717,580
25,576,657
25,940,895
24,900,395
45,776,627
44,108,296
48,973,776
54,305,662
59,527,935
59,106,624
52,687,919
58,133,033
75,118,525
75,118,52558,133,03352,687,91959,106,62459,527,93554,305,66248,973,77644,108,29645,776,62724,900,39525,940,89525,576,65725,717,58020,648,72320,408,92921,471,21722,182,11223,155,56922,162,77624,258,40423,866,81422,173,06223,393,94523,315,45922,788,04319,793,94118,815,90819,737,32619,887,22519,311,35218,558,95018,212,03119,135,96518,734,91218,190,39520,234,57818,169,50918,018,60217,734,64918,542,54116,129,72814,005,05414,106,20014,766,445
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,468,428
13,771,441
15,296,566
15,351,533
16,265,530
0
0
0
0
14,924,328
10,676,333
10,725,506
10,714,717
10,711,804
9,406,045
9,393,118
9,390,618
9,407,926
13,343,003
13,326,878
13,306,974
8,327,098
14,349,867
17,362,019
24,629,997
0
0
0024,629,99717,362,01914,349,8678,327,09813,306,97413,326,87813,343,0039,407,9269,390,6189,393,1189,406,04510,711,80410,714,71710,725,50610,676,33314,924,328000016,265,53015,351,53315,296,56613,771,44113,468,42800000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,468,428
13,771,441
15,296,566
15,351,533
16,265,530
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,852,598
32,270,009
24,629,997
35,600,221
41,228,685
41,228,68535,600,22124,629,99732,270,00928,852,5980000000000000000016,265,53015,351,53315,296,56613,771,44113,468,42800000000000000000
       Accounts payable 
752,983
642,231
862,156
504,401
692,328
499,270
615,743
529,232
803,461
722,747
438,036
549,882
770,299
631,924
772,776
739,704
692,038
813,635
736,066
1,319,649
1,188,300
0
1,176,727
1,024,017
1,142,858
768,917
985,017
737,858
646,523
698,261
1,044,295
819,276
942,777
1,050,970
708,256
815,541
633,829
1,013,740
1,079,267
783,540
1,366,545
5,111,462
500,848
541,976
541,976500,8485,111,4621,366,545783,5401,079,2671,013,740633,829815,541708,2561,050,970942,777819,2761,044,295698,261646,523737,858985,017768,9171,142,8581,024,0171,176,72701,188,3001,319,649736,066813,635692,038739,704772,776631,924770,299549,882438,036722,747803,461529,232615,743499,270692,328504,401862,156642,231752,983
       Other Current Liabilities 
3,366,975
3,355,181
2,582,477
3,884,353
3,720,515
2,685,379
2,906,534
2,977,254
4,767,903
3,137,780
3,851,530
4,477,992
3,772,068
4,338,267
5,000,711
5,658,870
5,596,841
4,533,845
5,286,434
6,771,828
7,375,626
8,628,415
5,711,675
7,530,589
7,797,954
6,402,537
7,154,847
9,892,439
9,239,702
8,042,336
7,914,198
10,528,374
10,464,169
10,882,485
10,400,590
19,890,055
17,966,002
22,296,376
31,281,690
1
0
0
-1
1
1-100131,281,69022,296,37617,966,00219,890,05510,400,59010,882,48510,464,16910,528,3747,914,1988,042,3369,239,7029,892,4397,154,8476,402,5377,797,9547,530,5895,711,6758,628,4157,375,6266,771,8285,286,4344,533,8455,596,8415,658,8705,000,7114,338,2673,772,0684,477,9923,851,5303,137,7804,767,9032,977,2542,906,5342,685,3793,720,5153,884,3532,582,4773,355,1813,366,975
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,805,576
22,194,584
22,607,628
22,843,953
23,682,886
23,682,88622,843,95322,607,62822,194,58421,805,576000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,707,644
5,937,576
5,742,065
5,482,562
6,093,805
2,926,681
4,926,132
5,027,990
13,209,418
2,006,399
9,842,350
9,060,460
14,107,081
20,136,808
20,148,807
20,199,789
0
0
0020,199,78920,148,80720,136,80814,107,0819,060,4609,842,3502,006,39913,209,4185,027,9904,926,1322,926,6816,093,8055,482,5625,742,0655,937,5762,707,64400000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-13,468,428
-13,771,441
-15,296,566
-15,351,533
-16,265,530
0
0
0
0
-14,924,328
-10,676,333
-10,725,506
-10,714,717
-10,711,804
-9,406,045
-9,393,118
-9,390,618
-9,407,926
-13,343,003
-13,326,878
-13,306,974
-8,327,098
-14,062,627
-17,066,066
-24,265,085
360,039
362,617
362,617360,039-24,265,085-17,066,066-14,062,627-8,327,098-13,306,974-13,326,878-13,343,003-9,407,926-9,390,618-9,393,118-9,406,045-10,711,804-10,714,717-10,725,506-10,676,333-14,924,3280000-16,265,530-15,351,533-15,296,566-13,771,441-13,468,42800000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
1
0
01011000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,521,530
1,456,915
1,392,300
277,685
263,070
248,455
233,840
219,225
204,610
189,995
175,380
160,765
146,150
131,535
116,920
102,305
87,690
73,075
58,460
43,845
29,230
14,615
0
0
0
0
0
0000014,61529,23043,84558,46073,07587,690102,305116,920131,535146,150160,765175,380189,995204,610219,225233,840248,455263,070277,6851,392,3001,456,9151,521,53000000000000000000
> Total Stockholder Equity
25,012,325
24,768,008
24,387,715
24,009,056
22,758,719
22,210,929
21,225,259
25,960,815
24,636,631
24,423,550
24,162,161
22,673,839
23,055,413
23,573,613
23,871,764
24,540,705
24,877,272
26,043,229
26,517,692
26,590,292
30,587,653
30,744,640
32,970,181
31,254,529
30,967,932
29,417,364
28,207,682
30,192,208
30,013,474
32,047,416
32,944,677
33,525,666
34,030,100
35,361,234
37,350,180
41,143,669
41,398,380
41,698,698
44,718,009
44,234,902
43,489,199
54,010,129
52,315,434
51,710,250
51,710,25052,315,43454,010,12943,489,19944,234,90244,718,00941,698,69841,398,38041,143,66937,350,18035,361,23434,030,10033,525,66632,944,67732,047,41630,013,47430,192,20828,207,68229,417,36430,967,93231,254,52932,970,18130,744,64030,587,65326,590,29226,517,69226,043,22924,877,27224,540,70523,871,76423,573,61323,055,41322,673,83924,162,16124,423,55024,636,63125,960,81521,225,25922,210,92922,758,71924,009,05624,387,71524,768,00825,012,325
   Common Stock
5,609,812
5,609,812
5,609,812
5,609,812
5,609,812
5,609,812
5,609,812
7,209,812
7,209,812
7,209,812
7,209,812
7,209,812
7,209,812
7,209,812
7,209,812
7,209,812
7,211,812
7,253,062
7,253,061
7,253,062
7,253,062
7,282,312
7,282,312
7,282,312
7,282,312
7,293,812
7,293,811
7,293,812
7,293,812
7,293,811
7,312,562
7,312,562
7,312,562
7,333,562
7,333,562
7,333,562
7,333,562
7,333,562
7,333,562
7,333,562
7,333,562
7,979,124
0
0
007,979,1247,333,5627,333,5627,333,5627,333,5627,333,5627,333,5627,333,5627,333,5627,312,5627,312,5627,312,5627,293,8117,293,8127,293,8127,293,8117,293,8127,282,3127,282,3127,282,3127,282,3127,253,0627,253,0627,253,0617,253,0627,211,8127,209,8127,209,8127,209,8127,209,8127,209,8127,209,8127,209,8127,209,8127,209,8125,609,8125,609,8125,609,8125,609,8125,609,8125,609,8125,609,812
   Retained Earnings Total Equity00000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,631,579
19,631,579
19,631,579
19,631,579
19,943,675
19,973,354
19,973,354
20,511,752
20,558,548
21,058,449
21,058,449
21,133,123
21,564,070
21,598,171
21,598,171
33,860,940
0
0
0033,860,94021,598,17121,598,17121,564,07021,133,12321,058,44921,058,44920,558,54820,511,75219,973,35419,973,35419,943,67519,631,57919,631,57919,631,57919,631,57900000000000000000000000000
   Treasury Stock00000000-165,681-165,681-165,681-165,681-165,681-165,681-165,681-165,681-165,681-165,681000-165,681-165,681-165,681-165,681-165,681-165,681-165,681-165,681-165,681-165,681-251,921-994,281-994,281-994,281-994,281-994,281-994,281-994,281-994,281-994,281-994,281-994,281-994,281
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,359,880
2,278,993
2,552,895
2,744,862
2,705,397
2,849,474
2,941,100
3,061,147
3,299,934
-10,301
3,347,848
3,407,472
3,783,097
3,822,294
3,977,785
3,794,851
3,660,803
3,633,783
3,562,898
3,549,133
3,456,612
3,283,951
1
-1
-1
0
0
00-1-113,283,9513,456,6123,549,1333,562,8983,633,7833,660,8033,794,8513,977,7853,822,2943,783,0973,407,4723,347,848-10,3013,299,9343,061,1472,941,1002,849,4742,705,3972,744,8622,552,8952,278,9932,359,88000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue32,630,976
Cost of Revenue-30,731,550
Gross Profit1,899,4261,899,426
 
Operating Income (+$)
Gross Profit1,899,426
Operating Expense-40,818,026
Operating Income-8,187,050-38,918,600
 
Operating Expense (+$)
Research Development453,676
Selling General Administrative2,728,951
Selling And Marketing Expenses0
Operating Expense40,818,0263,182,627
 
Net Interest Income (+$)
Interest Income1,030,136
Interest Expense-3,764,332
Other Finance Cost-2
Net Interest Income-2,734,198
 
Pretax Income (+$)
Operating Income-8,187,050
Net Interest Income-2,734,198
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,833,194-8,187,050
EBIT - interestExpense = -3,764,332
-4,877,635
-1,113,303
Interest Expense3,764,332
Earnings Before Interest and Taxes (EBIT)0-8,068,862
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-11,833,194
Tax Provision--2,882,859
Net Income From Continuing Ops-8,950,336-8,950,336
Net Income-4,877,635
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,734,198
 

Technical Analysis of Biotoxtech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotoxtech. The general trend of Biotoxtech is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotoxtech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotoxtech Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5,520 < 6,930 < 7,120.

The bearish price targets are: .

Tweet this
Biotoxtech Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotoxtech Co. Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotoxtech Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotoxtech Co. Ltd. The current macd is -147.188913.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotoxtech price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biotoxtech. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biotoxtech price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biotoxtech Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBiotoxtech Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotoxtech Co. Ltd. The current adx is 25.42.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biotoxtech shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Biotoxtech Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotoxtech Co. Ltd. The current sar is 5,572.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biotoxtech Co. Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotoxtech Co. Ltd. The current rsi is 41.84. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biotoxtech Co. Ltd Daily Relative Strength Index (RSI) ChartBiotoxtech Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotoxtech Co. Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotoxtech price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biotoxtech Co. Ltd Daily Stochastic Oscillator ChartBiotoxtech Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotoxtech Co. Ltd. The current cci is -79.07075874.

Biotoxtech Co. Ltd Daily Commodity Channel Index (CCI) ChartBiotoxtech Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotoxtech Co. Ltd. The current cmo is -17.89040242.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biotoxtech Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartBiotoxtech Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotoxtech Co. Ltd. The current willr is -64.70588235.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biotoxtech is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biotoxtech Co. Ltd Daily Williams %R ChartBiotoxtech Co. Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotoxtech Co. Ltd.

Biotoxtech Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotoxtech Co. Ltd. The current atr is 219.44.

Biotoxtech Co. Ltd Daily Average True Range (ATR) ChartBiotoxtech Co. Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotoxtech Co. Ltd. The current obv is 68,925,068.

Biotoxtech Co. Ltd Daily On-Balance Volume (OBV) ChartBiotoxtech Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotoxtech Co. Ltd. The current mfi is 24.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Biotoxtech Co. Ltd Daily Money Flow Index (MFI) ChartBiotoxtech Co. Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotoxtech Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Biotoxtech Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotoxtech Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.842
Ma 20Greater thanMa 505,751.500
Ma 50Greater thanMa 1005,836.200
Ma 100Greater thanMa 2005,977.200
OpenGreater thanClose5,430.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biotoxtech with someone you think should read this too:
  • Are you bullish or bearish on Biotoxtech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotoxtech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotoxtech Co. Ltd

I send you an email if I find something interesting about Biotoxtech Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Biotoxtech Co. Ltd.

Receive notifications about Biotoxtech Co. Ltd in your mailbox!